As the demand for Natural Health Products (NHP) increases, so too does the concern by regulatory agencies that newly discovered NHPs are safe for human usage. As such, for novel compounds which are not already consumed for traditional medicinal purposes, regulatory agencies may request preclinical testing be accomplished to ensure that they are safe for human use. ITR Laboratories Canada can perform preclinical toxicology studies in support of these requirements. In addition, ITR Laboratories Canada can also provide early stage models to demonstrate efficacy of an NHP in support of therapeutic benefits before moving into clinical efficacy trials.
